Literature DB >> 8290801

Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause.

N Hiwatari1, S Shimura, T Takishima.   

Abstract

Idiopathic pulmonary fibrosis (IPF) and pulmonary emphysema (PE) have distinct clinical and pathological characteristics, and have been considered to be separate disorders. However, recent animal experiments have suggested that, with regard to their pathogenesis, the diseases have some features in common. However, there are no clinical data supporting this hypothesis. We report here 9 patients (all male, 67 +/- 2 years, mean +/- SE) who had PE followed by IPF. They were found among 152 PE patients who came to Tohoku University Hospital during the past 15 years (1976-1991). All patients were male and heavy smokers and 2 patients also had prostate cancer and gastric cancer, respectively. Three patients were alive during this study and had been diagnosed as having IPF and PE by the combination of transbronchial biopsy, selective alveolobronchogram, CT examination and lung function tests. The diagnosis of IPF and PE in the other patients was based on the pathological findings of autopsied lungs in addition to clinical findings. All patients showed PE mainly in the upper lobes and IPF in the lower lobes. In all patients, in addition to all known causes of pulmonary fibrosis, the possibilities that chronic or recurrent infections in PE induced pulmonary fibrosis and that IPF produced emphysematous changes were carefully excluded by medical records and pathological findings. It is not clear whether the occurrence of emphysema and pulmonary fibrosis in these cases is coincidental, or whether the two diseases are linked by a common pathogenetic pathway.

Entities:  

Mesh:

Year:  1993        PMID: 8290801     DOI: 10.1159/000196235

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  11 in total

1.  Smoking-related idiopathic interstitial pneumonia.

Authors:  Kevin R Flaherty; Charlene Fell; Marie-Christine Aubry; Kevin Brown; Thomas Colby; Ulrich Costabel; Teri J Franks; Barry H Gross; David M Hansell; Ella Kazerooni; Dong Soon Kim; Talmadge E King; Masanori Kitachi; David Lynch; Jeff Myers; Sonoko Nagai; Andrew G Nicholson; Venerino Poletti; Ganesh Raghu; Moises Selman; Galen Toews; William Travis; Athol U Wells; Robert Vassallo; Fernando J Martinez
Journal:  Eur Respir J       Date:  2014-07-25       Impact factor: 16.671

Review 2.  Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.

Authors:  Huijin Lin; Shanping Jiang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 3.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

Review 4.  Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know.

Authors:  Federica Ciccarese; Domenico Attinà; Maurizio Zompatori
Journal:  Radiol Med       Date:  2016-02-19       Impact factor: 3.469

5.  Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners.

Authors:  C Frette; M P Jacob; S M Wei; J P Bertrand; P Laurent; F Kauffmann; Q T Pham
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

6.  The syndrome of combined pulmonary fibrosis and emphysema.

Authors:  Ines Zendah; Houda Gharsalli; Amel Khattab; Habib Ghedira
Journal:  Tanaffos       Date:  2011

7.  Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.

Authors:  Massa Zantah; Yaniv Dotan; Chandra Dass; Hauqing Zhao; Nathaniel Marchetti; Gerard J Criner
Journal:  Respir Res       Date:  2020-06-30

Review 8.  Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management.

Authors:  René Hage; Fiorenza Gautschi; Carolin Steinack; Macé M Schuurmans
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-28

9.  An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features.

Authors:  Minoru Inomata; Soichiro Ikushima; Nobuyasu Awano; Keisuke Kondoh; Kohta Satake; Masahiro Masuo; Yuji Kusunoki; Atsuko Moriya; Hiroyuki Kamiya; Tsunehiro Ando; Noriyo Yanagawa; Toshio Kumasaka; Takashi Ogura; Fumikazu Sakai; Arata Azuma; Akihiko Gemma; Tamiko Takemura
Journal:  BMC Pulm Med       Date:  2014-06-28       Impact factor: 3.317

10.  The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients.

Authors:  Takumi Kinjo; Yoshiaki Kitaguchi; Yunden Droma; Masanori Yasuo; Yosuke Wada; Fumika Ueno; Masao Ota; Masayuki Hanaoka
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.